BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAFV600E mutation

Author: Young Kate   Minchom Anna   Larkin James  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.8, Iss.5, 2012-05, pp. : 499-507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content